Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...
The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential conversion portfolio. Its first foray into the typology was at Pearl House in the ...
Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Shares of Pfizer Inc. PFE rallied 1.09% to $26.91 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,071.17 and ...
Pfizer Inc. (PFE), founded in 1849 and headquartered in New York City, is one of the world's largest pharmaceutical companies dedicated to developing and delivering innovative medicines and vaccines.
Swiss biopharma company BioVersys said on Tuesday it plans to list on the Swiss stock exchange in the first quarter with an initial public offering that aims to raise around 80 million Swiss francs ...
in coordination with Manila – a development analysts say underscores the growing regional challenge of combating transnational crime. The Singapore Police Force told local newspaper The Straits ...
Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units. The company makes a wide range of products, including Panadol pain relief tablets and Centrum vitamins.
During an afternoon discussion with J.P. Morgan analyst Chris Schott, Pfizer CEO Albert Bourla said there’s “clearly a LOE wave that is coming” for the company. The LOE wave will cost Pfizer ...
Pfizer (PFE.N), opens new tab will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (HLN.L), opens new tab, lowering its stake in the British consumer healthcare company to about 7. ...